COPD 患者肺功能评估的重要性。
The importance of the assessment of pulmonary function in COPD.
机构信息
Pulmonary, Critical Care, Sleep and Allergy Division, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5910, USA.
出版信息
Med Clin North Am. 2012 Jul;96(4):745-52. doi: 10.1016/j.mcna.2012.04.011. Epub 2012 May 31.
Abstract
Spirometry is the gold standard for making the diagnosis of COPD. It should be performed in every case of suspected COPD. Other pulmonary functions, such as lung volumes, can give insight into physiologic consequences of COPD, such as hyperinflation. Pulmonary function testing can also aid in assessing the severity of disease and in managing the disease after diagnosis is made.
摘要
肺量测定法是诊断 COPD 的金标准。对于疑似 COPD 的每一病例，均应进行肺量测定法。其他肺功能，如肺容积，可深入了解 COPD 的生理后果，如过度充气。肺功能检查也有助于评估疾病的严重程度，并在确诊后管理疾病。
相似文献
1
The importance of the assessment of pulmonary function in COPD.COPD 患者肺功能评估的重要性。
Med Clin North Am. 2012 Jul;96(4):745-52. doi: 10.1016/j.mcna.2012.04.011. Epub 2012 May 31.
2
Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.支气管扩张剂后肺功能测试对区分稳定期、中重度慢性阻塞性肺疾病（COPD）和哮喘的诊断价值。
Int J Chron Obstruct Pulmon Dis. 2008;3(4):693-9. doi: 10.2147/copd.s948.
3
Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.伴有肺过度充气的早期慢性阻塞性肺疾病患者肺功能较差，但支气管扩张剂反应性较好。
Int J Chron Obstruct Pulmon Dis. 2016 Oct 7;11:2519-2526. doi: 10.2147/COPD.S110021. eCollection 2016.
4
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
5
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.
6
Comparison of spirometric changes in the response to bronchodilators of patients with asthma or chronic obstructive pulmonary disease.哮喘或慢性阻塞性肺疾病患者对支气管扩张剂反应的肺量计变化比较。
J Bras Pneumol. 2008 Sep;34(9):675-82. doi: 10.1590/s1806-37132008000900007.
7
Bronchodilator response of advanced lung function parameters depending on COPD severity.根据慢性阻塞性肺疾病（COPD）严重程度，晚期肺功能参数的支气管扩张剂反应。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 25;11:2939-2950. doi: 10.2147/COPD.S111573. eCollection 2016.
8
Use of clinical characteristics to predict spirometric classification of obstructive lung disease.利用临床特征预测阻塞性肺疾病的肺量计分类
Int J Chron Obstruct Pulmon Dis. 2018 Mar 12;13:889-902. doi: 10.2147/COPD.S153426. eCollection 2018.
9
The effect of comorbidities on COPD assessment: a pilot study.合并症对慢性阻塞性肺疾病评估的影响：一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2015 Feb 25;10:429-38. doi: 10.2147/COPD.S76124. eCollection 2015.
10
Preoperative Spirometry in Patients With Known or Suspected Chronic Obstructive Pulmonary Disease Undergoing Major Surgery: The Prospective Observational PREDICT Study.已知或疑似患有慢性阻塞性肺疾病的患者在接受大手术前的肺量计检查：前瞻性观察性PREDICT研究
Anesth Analg. 2023 Oct 1;137(4):806-818. doi: 10.1213/ANE.0000000000006235. Epub 2022 Nov 1.
引用本文的文献
1
Reliability and usability of a portable spirometer compared to a laboratory spirometer.便携式肺量计与实验室肺量计相比的可靠性和可用性。
BMC Pulm Med. 2025 May 10;25(1):228. doi: 10.1186/s12890-025-03690-1.
2
Alterations in tidal volume over recording time during pulmonary function testing by barometric whole-body plethysmography in client-owned cats: a multicenter retrospective investigation.通过气压式全身体积描记法对客户拥有的猫进行肺功能测试期间，潮气量在记录时间内的变化：一项多中心回顾性研究。
BMC Vet Res. 2025 May 1;21(1):304. doi: 10.1186/s12917-025-04774-0.
3
Identification of Candidate Lung Function-Related Plasma Proteins to Pinpoint Drug Targets for Common Pulmonary Diseases: A Comprehensive Multi-Omics Integration Analysis.鉴定与肺功能相关的候选血浆蛋白以确定常见肺部疾病的药物靶点：一项全面的多组学整合分析
Curr Issues Mol Biol. 2025 Mar 1;47(3):167. doi: 10.3390/cimb47030167.
4
Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.慢性阻塞性肺疾病（COPD）中肺功能测试的挑战与未来：迈向COPD的早期诊断
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):413-418. doi: 10.4046/trd.2025.0009. Epub 2025 Mar 25.
5
Preclinical Identification of Poorly Controlled COPD: Patients with a Single Moderate Exacerbation Matter Too.控制不佳的慢性阻塞性肺疾病的临床前识别：单次中度加重的患者也很重要。
J Clin Med. 2024 Dec 24;14(1):22. doi: 10.3390/jcm14010022.
6
Poor treatment outcomes of acute exacerbations of chronic obstructive pulmonary disease and their associated factors among admitted patients in East Gojjam, 2023.2023年东戈贾姆地区住院患者慢性阻塞性肺疾病急性加重的治疗效果不佳及其相关因素
Front Med (Lausanne). 2024 Nov 20;11:1434166. doi: 10.3389/fmed.2024.1434166. eCollection 2024.
7
Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease.一组有或无肺部疾病的α-1抗胰蛋白酶缺乏症患者的肝脏特征分析
J Clin Transl Hepatol. 2024 Oct 28;12(10):845-856. doi: 10.14218/JCTH.2024.00201. Epub 2024 Sep 14.
8
Artificial intelligence in COPD CT images: identification, staging, and quantitation.人工智能在 COPD CT 图像中的应用：识别、分期和定量。
Respir Res. 2024 Aug 22;25(1):319. doi: 10.1186/s12931-024-02913-z.
9
Effects of different traditional Chinese exercises on pulmonary function in patients with stable chronic obstructive pulmonary disease: a network meta-analysis.不同中医运动疗法对稳定期慢性阻塞性肺疾病患者肺功能的影响：网状 Meta 分析。
BMC Complement Med Ther. 2024 Aug 14;24(1):304. doi: 10.1186/s12906-024-04609-9.
10
Substances of abuse and their effect on SAR-CoV-2 pathogenesis.滥用物质及其对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病机制的影响。
NeuroImmune Pharm Ther. 2023 Jul 31;2(3):301-316. doi: 10.1515/nipt-2023-0004. eCollection 2023 Sep.
本文引用的文献
1
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.慢性阻塞性肺疾病稳定期的诊断与管理：美国医师学会、美国胸科学会、美国胸科学会和欧洲呼吸学会的临床实践指南更新。
Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
2
Performing slow vital capacity in older people with and without cognitive impairment--is it useful?在有认知障碍和无认知障碍的老年人中进行缓慢肺活量测定——有用吗？
Age Ageing. 2010 Sep;39(5):588-91. doi: 10.1093/ageing/afq084. Epub 2010 Jul 12.
3
Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry.慢性阻塞性肺疾病的严重程度分期：支气管扩张剂预后肺量计检查的差异。
Yonsei Med J. 2009 Oct 31;50(5):672-6. doi: 10.3349/ymj.2009.50.5.672. Epub 2009 Oct 21.
4
Patient-reported dyspnea in COPD reliability and association with stage of disease.慢性阻塞性肺疾病患者报告的呼吸困难：可靠性及其与疾病阶段的关联
Chest. 2009 Dec;136(6):1473-1479. doi: 10.1378/chest.09-0934. Epub 2009 Aug 20.
5
Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.肺量计在慢性阻塞性肺疾病诊断中的应用及改善医疗质量的努力。
Transl Res. 2009 Sep;154(3):103-10. doi: 10.1016/j.trsl.2009.06.003. Epub 2009 Jul 8.
6
Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis.FEV1/FEV6是否应取代FEV1/FVC比值来检测气道阻塞？一项荟萃分析。
Chest. 2009 Apr;135(4):991-998. doi: 10.1378/chest.08-0723.
7
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.采用FEV1/FVC比值的正常下限可减少气道阻塞的误诊。
Thorax. 2008 Dec;63(12):1046-51. doi: 10.1136/thx.2008.098483. Epub 2008 Sep 11.
8
The modified BODE index: validation with mortality in COPD.改良的BODE指数：慢性阻塞性肺疾病死亡率的验证
Eur Respir J. 2008 Nov;32(5):1269-74. doi: 10.1183/09031936.00138507. Epub 2008 Jun 25.
9
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes.使用FEV1/FVC<70%作为固定截断值对年轻成年人气流阻塞的低估：临床和功能结局的纵向评估
Thorax. 2008 Dec;63(12):1040-5. doi: 10.1136/thx.2008.095554. Epub 2008 May 20.
10
Spirometry utilization for COPD: how do we measure up?慢性阻塞性肺疾病（COPD）的肺量计使用情况：我们做得如何？
Chest. 2007 Aug;132(2):403-9. doi: 10.1378/chest.06-2846. Epub 2007 Jun 5.
Zotero 插件